Desq Long
Sign in
SEC FORM 4
$0.00

AN2 Therapeutics, Inc. (ANTX)

Acquisition (code A) of 116,667 shares at $0 per share.

Reporting Person Trenor Cameron C. III · Officer Title Chief Medical Officer · Transaction Code A

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001193125-26-393274 · filed 2026-09-16 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "AN2 Therapeutics, Inc. (ANTX)." Disclosed 2026-09-16. https://desqlong.com/cards/0001193125-26-393274-1 (retrieved 2026-09-26).